Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Hepatitis Therapy
Research from University of Sao Paulo, Division of Gastroenterology yields new findings on acute hepatitis therapy
March 16th, 2008
Research findings, 'Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis,' are discussed in a new report. "Patients with end-stage renal disease (ESRD) undergoing hemodialysis are a risk group for hepatitis C virus (HCV) infection. The characteristics of acute hepatitis C infection in this population are not well known," researchers in Brazil report. "To evaluate the clinical and laboratory characteristics of acute hepatitis C in ESRD patients treated with hemodialysis. ESRD patients on hemodialysis with acute hepatitis C, characterized by elevated alanine aminotransferase (ALT) followed by anti-HCV...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-16)
|
